Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04404816
Other study ID # 072015
Secondary ID
Status Completed
Phase Phase 1/Phase 2
First received
Last updated
Start date January 2017
Est. completion date December 2018

Study information

Verified date June 2020
Source Poznan University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The use of a mixture of helium with oxygen (heliox) as a breathing gas may be beneficial due to its unique physical properties, such as low density and high carbon dioxide (CO2) diffusion coefficient. In previous studies in neonates with respiratory failure, conventional ventilation with heliox was associated with improved oxygenation and selected respiratory parameters. The use of heliox may increase the effectiveness of intermittent nasal positive pressure ventilation (NIPPV), but knowledge about the effects of such therapy on newborns is limited.The use of non- invasive neurally adjusted ventilatory assist (NIV-NAVA) allows synchronization and assessment of electrical activity of the diaphragm (EaDI) during heliox administration in premature babies with respiratory failure.


Description:

Aim of the study was to assess of the impact of non-invasive ventilation with heliox on respiratory function, diaphragm bioelectrical activity, cerebral oxygenation and selected vital signs in premature neonates with respiratory failure. 23 neonates ≤32 weeks gestational age (GA) were enrolled in the study. Patients were eligible for inclusion when ventilated due to respiratory failure, and in group 1 (n=12) on NIV as primary modality with oxygen requirement of 0.25-0.4 in the first 72 hours of life, or in group 2 (n=11) ready to extubate according to the given criteria. Newborns were ventilated with NIV NAVA and standard breathing gas (air-oxygen) at baseline. Heliox was introduced for 3 hours, followed by 3 hours of air-oxygen. NAVA level was kept constant and pulse oximeter oxygen saturation (SpO2) kept in range of 90-95%. Recorded parameters included heart rate (HR), SpO2 and cerebral tissue oxygenation (StO2). Selected ventilation parameters: peak inspiratory pressure (PIP), positive end-expiratory pressure (PEEP), mean airway pressure (MAP), air leakage during NIV, fraction of inspired oxygen (FiO2) as well as electrical activity of the diaphragm (EaDI mean, minimum and maximum) were also acquired. Blood gas analysis was performed in each period of the study. Statistical analysis was completed with ANOVA Friedman's test and single-factor repeated-measures analysis of variance.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date December 2018
Est. primary completion date December 2018
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria (Group 1):

- GA under 33 weeks GA

- Need for NIV due to clinical symptoms of respiratory distress in course of RDS

- FiO2=0.25-0.4

- Enrollment within first 72 hours of life

- Parental consent

Inclusion Criteria (Group 2):

- GA under 33 weeks GA

- Need for MV due to clinical symptoms of respiratory distress

- at least one failed attempted extubation

- Parental consent

Exclusion Criteria:

- Major congenital anomalies

- Deteriorating pulmonary function despite NIV and the need for intubation and conventional mechanical ventilation (CMV) (Preliminary criteria: pH< 7.22, carbon dioxide partial pressure (pCO2) >65)

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
heliox
NIV-NAVA with a conventional gas mixture (air-oxygen) at baseline, 3 hours of NIV-NAVA with heliox and return to NIV-NAVA with air-oxygen.

Locations

Country Name City State
Poland Gynecological and obstetric teaching hospital, Departament of Neonatology, Polna street 33 Poznan Great Poland

Sponsors (2)

Lead Sponsor Collaborator
Poznan University of Medical Sciences European Society for Paediatric Research

Country where clinical trial is conducted

Poland, 

References & Publications (13)

Beck J, Reilly M, Grasselli G, Qui H, Slutsky AS, Dunn MS, Sinderby CA. Characterization of neural breathing pattern in spontaneously breathing preterm infants. Pediatr Res. 2011 Dec;70(6):607-13. doi: 10.1203/PDR.0b013e318232100e. — View Citation

Brooks LJ, DiFiore JM, Martin RJ. Assessment of tidal volume over time in preterm infants using respiratory inductance plethysmography, The CHIME Study Group. Collaborative Home Infant Monitoring Evaluation. Pediatr Pulmonol. 1997 Jun;23(6):429-33. — View Citation

Colnaghi M, Pierro M, Migliori C, Ciralli F, Matassa PG, Vendettuoli V, Mercadante D, Consonni D, Mosca F. Nasal continuous positive airway pressure with heliox in preterm infants with respiratory distress syndrome. Pediatrics. 2012 Feb;129(2):e333-8. doi: 10.1542/peds.2011-0532. Epub 2012 Jan 30. — View Citation

Elleau C, Galperine RI, Guenard H, Demarquez JL. Helium-oxygen mixture in respiratory distress syndrome: a double-blind study. J Pediatr. 1993 Jan;122(1):132-6. Erratum in: J Pediatr 1993 Aug;123(2):336. — View Citation

Jassar RK, Vellanki H, Zhu Y, Hesek A, Wang J, Rodriguez E, Wu J, Shaffer TH, Wolfson MR. High flow nasal cannula (HFNC) with Heliox decreases diaphragmatic injury in a newborn porcine lung injury model. Pediatr Pulmonol. 2014 Dec;49(12):1214-22. doi: 10.1002/ppul.23000. Epub 2014 Feb 5. — View Citation

Kuligowski J, Escobar J, Quintás G, Lliso I, Torres-Cuevas I, Nuñez A, Cubells E, Rook D, van Goudoever JB, Vento M. Analysis of lipid peroxidation biomarkers in extremely low gestational age neonate urines by UPLC-MS/MS. Anal Bioanal Chem. 2014 Jul;406(18):4345-56. doi: 10.1007/s00216-014-7824-6. Epub 2014 May 11. — View Citation

Kuligowski J, Torres-Cuevas I, Quintás G, Rook D, van Goudoever JB, Cubells E, Asensi M, Lliso I, Nuñez A, Vento M, Escobar J. Assessment of oxidative damage to proteins and DNA in urine of newborn infants by a validated UPLC-MS/MS approach. PLoS One. 2014 Apr 2;9(4):e93703. doi: 10.1371/journal.pone.0093703. eCollection 2014. — View Citation

Nawab US, Touch SM, Irwin-Sherman T, Blackson TJ, Greenspan JS, Zhu G, Shaffer TH, Wolfson MR. Heliox attenuates lung inflammation and structural alterations in acute lung injury. Pediatr Pulmonol. 2005 Dec;40(6):524-32. — View Citation

Oei GT, Weber NC, Hollmann MW, Preckel B. Cellular effects of helium in different organs. Anesthesiology. 2010 Jun;112(6):1503-10. doi: 10.1097/ALN.0b013e3181d9cb5e. Review. — View Citation

Sinderby C, Beck J, Spahija J, Weinberg J, Grassino A. Voluntary activation of the human diaphragm in health and disease. J Appl Physiol (1985). 1998 Dec;85(6):2146-58. — View Citation

Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Vento M, Halliday HL; European Association of Perinatal Medicine. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants--2013 update. Neonatology. 2013;103(4):353-68. doi: 10.1159/000349928. Epub 2013 May 31. — View Citation

Szczapa T, Gadzinowski J, Moczko J, Merritt TA. Heliox for mechanically ventilated newborns with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed. 2014 Mar;99(2):F128-33. doi: 10.1136/archdischild-2013-303988. Epub 2013 Nov 15. — View Citation

Szczapa T, Gadzinowski J. Use of heliox in the management of neonates with meconium aspiration syndrome. Neonatology. 2011;100(3):265-70. doi: 10.1159/000327531. Epub 2011 Jun 23. — View Citation

* Note: There are 13 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary baseline minimal electric activity of the diaphragm (EaDI min) Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI min [mcV, microvolts] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured at baseline
Primary baseline mean electric activity of the diaphragm (EaDI mean) Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI mean [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured at baseline
Primary baseline maximal electric activity of the diaphragm (EaDI max) Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI max [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured at baseline
Primary minimal electric activity of the diaphragm (EaDI min) after 15 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI min [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 15 minutes of heliox ventilation
Primary mean electric activity of the diaphragm (EaDI mean) after 15 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI mean [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 15 minutes of heliox ventilation
Primary maximal electric activity of the diaphragm (EaDI max) after 15 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI max [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 15 minutes of heliox ventilation
Primary minimal electric activity of the diaphragm (EaDI min) after 60 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI min [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 60 minutes of heliox ventilation
Primary mean electric activity of the diaphragm (EaDI mean) after 60 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI mean [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 60 minutes of heliox ventilation
Primary maximal electric activity of the diaphragm (EaDI max) after 60 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI max [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 60 minutes of heliox ventilation
Primary minimal electric activity of the diaphragm (EaDI min) after 180 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI min [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 180 minutes of heliox ventilation
Primary mean electric activity of the diaphragm (EaDI mean) after 180 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI mean [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 180 minutes of heliox ventilation
Primary maximal electric activity of the diaphragm (EaDI max) after 180 minutes of heliox Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI max [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 180 minutes of heliox ventilation
Primary minimal electric activity of the diaphragm (EaDI min) after 15 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI min [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 15 minutes since the return to ventilation with standard mixture
Primary mean electric activity of the diaphragm (EaDI mean) after 15 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI mean [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 15 minutes since the return to ventilation with standard mixture
Primary maximal electric activity of the diaphragm (EaDI max) after 15 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI max [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 15 minutes since the return to ventilation with standard mixture
Primary minimal electric activity of the diaphragm (EaDI min) after 60 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI min [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 60 minutes since the return to ventilation with standard mixture
Primary mean electric activity of the diaphragm (EaDI mean) after 60 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI mean [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 60 minutes since the return to ventilation with standard mixture
Primary maximal electric activity of the diaphragm (EaDI max) after 60 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI max [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 60 minutes since the return to ventilation with standard mixture
Primary minimal electric activity of the diaphragm (EaDI min) after 180 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI min [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 180 minutes since the return to ventilation with standard mixture
Primary mean electric activity of the diaphragm (EaDI mean) after 180 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI mean [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 180 minutes since the return to ventilation with standard mixture
Primary maximal electric activity of the diaphragm (EaDI max) after 180 minutes of standard mixture Using the NAVA (neurally adjusted ventilatory assist) module of the Maquet Servo-i ventilator and "Servo-tracker" software EaDI max [mcV] values will be recorded during the study and their values will be compared between the heliox and air-oxygen NIV (non -invasive ventilation). measured after 180 minutes since the return to ventilation with standard mixture
Primary baseline PIP (peak inspiratory pressure) PIP [cm H2O, centimeters of water] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured at baseline
Primary baseline PEEP (positive end-expiratory pressure) PEEP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured at baseline
Primary baseline MAP (mean airway pressure) MAP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured at baseline
Primary PIP (peak inspiratory pressure) after 15 minutes of heliox PIP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes of heliox ventilation
Primary PIP (peak inspiratory pressure) after 60 minutes of heliox PIP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes of heliox ventilation
Primary PIP (peak inspiratory pressure) after 180 minutes of heliox PIP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes of heliox ventilation
Primary PIP (peak inspiratory pressure) after 15 minutes of standard mixture PIP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes since the return to ventilation with standard mixture
Primary PIP (peak inspiratory pressure) after 60 minutes of standard mixture PIP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes since the return to ventilation with standard mixture
Primary PIP (peak inspiratory pressure) after 180 minutes of standard mixture PIP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes since the return to ventilation with standard mixture
Primary PEEP (positive end-expiratory pressure) after 15 minutes of heliox PEEP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes of heliox ventilation
Primary PEEP (positive end-expiratory pressure) after 60 minutes of heliox PEEP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes of heliox ventilation
Primary PEEP (positive end-expiratory pressure) after 180 minutes of heliox PEEP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes of heliox ventilation
Primary PEEP (positive end-expiratory pressure) after 15 minutes of standard mixture PEEP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes since the return to ventilation with standard mixture
Primary PEEP (positive end-expiratory pressure) after 60 minutes of standard mixture PEEP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes since the return to ventilation with standard mixture
Primary PEEP (positive end-expiratory pressure) after 180 minutes of standard mixture PEEP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes since the return to ventilation with standard mixture
Primary MAP (mean airway pressure) after 15 minutes of heliox MAP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes of heliox ventilation
Primary MAP (mean airway pressure) after 60 minutes of heliox MAP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes of heliox ventilation
Primary MAP (mean airway pressure) after 180 minutes of heliox MAP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes of heliox ventilation
Primary MAP (mean airway pressure) after 15 minutes of standard ventilation MAP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes since the return to ventilation with standard mixture
Primary MAP (mean airway pressure) after 60 minutes of standard ventilation MAP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes since the return to ventilation with standard mixture
Primary MAP (mean airway pressure) after 180 minutes of standard ventilation MAP [cm of water / cm H2O] will be recorded by Servo-tracker software and the values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes since the return to ventilation with standard mixture
Primary baseline NIV leakage gas leakage fraction [%] during NIV (non-invasive ventilation) recorded by Servo-tracker software their values will be compared between the heliox and air-oxygen NIV. measured at baseline
Primary NIV leakage after 15 minutes of heliox gas leakage fraction [%] during NIV (non-invasive ventilation) recorded by Servo-tracker software their values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes of heliox ventilation
Primary NIV leakage after 60 minutes of heliox gas leakage fraction [%] during NIV (non-invasive ventilation) recorded by Servo-tracker software their values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes of heliox ventilation
Primary NIV leakage after 180 minutes of heliox gas leakage fraction [%] during NIV (non-invasive ventilation) recorded by Servo-tracker software their values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes of heliox ventilation
Primary NIV leakage after 15 minutes of standard mixture gas leakage fraction [%] during NIV (non-invasive ventilation) recorded by Servo-tracker software their values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes since the return to ventilation with standard mixture
Primary NIV leakage after 60 minutes of standard mixture gas leakage fraction [%] during NIV (non-invasive ventilation) recorded by Servo-tracker software their values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes since the return to ventilation with standard mixture
Primary NIV leakage after 180 minutes of standard mixture gas leakage fraction [%] during NIV (non-invasive ventilation) recorded by Servo-tracker software their values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes since the return to ventilation with standard mixture
Secondary baseline cerebral oxygenation Cerebral tissue oxygen saturation (StO2; [%]) measured with near infrared spectroscopy (NIRS) - NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA - their values will be compared between the heliox and air-oxygen NIV. measured at baseline
Secondary Cerebral oxygenation after 15 minutes of heliox Cerebral tissue oxygen saturation (StO2; [%]) measured with near infrared spectroscopy (NIRS) - NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA - their values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes of heliox ventilation
Secondary Cerebral oxygenation after 60 minutes of heliox Cerebral tissue oxygen saturation (StO2; [%]) measured with near infrared spectroscopy (NIRS) - NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA - their values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes of heliox ventilation
Secondary Cerebral oxygenation after 180 minutes of heliox Cerebral tissue oxygen saturation (StO2; [%]) measured with near infrared spectroscopy (NIRS) - NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA - their values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes of heliox ventilation
Secondary Cerebral oxygenation after 15 minutes of standard mixture Cerebral tissue oxygen saturation (StO2; [%]) measured with near infrared spectroscopy (NIRS) - NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA - their values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes since the return to standard mixture ventilation
Secondary Cerebral oxygenation after 60 minutes of standard mixture Cerebral tissue oxygen saturation (StO2; [%]) measured with near infrared spectroscopy (NIRS) - NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA - their values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes since the return to standard mixture ventilation
Secondary Cerebral oxygenation after 180 minutes of standard mixture Cerebral tissue oxygen saturation (StO2; [%]) measured with near infrared spectroscopy (NIRS) - NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA - their values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes since the return to standard mixture ventilation
Secondary baseline oxygen requirements Fraction of inspired oxygen (FiO2) will be recorded during heliox and air-oxygen NIV to maintain the saturation assessed by pulse oximetry (SpO2) in 90-95% range; their values will be compared between the phases of the study recorded at baseline
Secondary oxygen requirements after 15 minutes of heliox Fraction of inspired oxygen (FiO2) will be recorded during heliox and air-oxygen NIV to maintain the saturation assessed by pulse oximetry (SpO2) in 90-95% range; their values will be compared between the phases of the study recorded after 15 minutes of heliox ventilation
Secondary oxygen requirements after 60 minutes of heliox Fraction of inspired oxygen (FiO2) will be recorded during heliox and air-oxygen NIV to maintain the saturation assessed by pulse oximetry (SpO2) in 90-95% range; their values will be compared between the phases of the study recorded after 60 minutes of heliox ventilation
Secondary oxygen requirements after 180 minutes of heliox Fraction of inspired oxygen (FiO2) will be recorded during heliox and air-oxygen NIV to maintain the saturation assessed by pulse oximetry (SpO2) in 90-95% range; their values will be compared between the phases of the study recorded after 180 minutes of heliox ventilation
Secondary oxygen requirements after 15 minutes of standard ventilation Fraction of inspired oxygen (FiO2) will be recorded during heliox and air-oxygen NIV to maintain the saturation assessed by pulse oximetry (SpO2) in 90-95% range; their values will be compared between the phases of the study recorded after 15 minutes since the return to standard mixture ventilation
Secondary oxygen requirements after 60 minutes of standard ventilation Fraction of inspired oxygen (FiO2) will be recorded during heliox and air-oxygen NIV to maintain the saturation assessed by pulse oximetry (SpO2) in 90-95% range; their values will be compared between the phases of the study recorded after 60 minutes since the return to standard mixture ventilation
Secondary oxygen requirements after 180 minutes of standard ventilation Fraction of inspired oxygen (FiO2) will be recorded during heliox and air-oxygen NIV to maintain the saturation assessed by pulse oximetry (SpO2) in 90-95% range; their values will be compared between the phases of the study recorded after 180 minutes since the return to standard mixture ventilation
Secondary baseline capillary blood gas analysis Cobas B 221; Roche, Germany; the values will be compared between the heliox and air-oxygen NIV. blood samples drawn at baseline
Secondary capillary blood gas analysis after 3 hours of heliox Cobas B 221; Roche, Germany; the values will be compared between the heliox and air-oxygen NIV. blood samples drawn after 3 hours of heliox ventilation
Secondary capillary blood gas analysis after 3 hours of standard mixture Cobas B 221; Roche, Germany; the values will be compared between the heliox and air-oxygen NIV. blood samples drawn after 3 hours of standard mixture ventilation
Secondary baseline heart rate heart rate (HR, [bpm / beats per minute]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA), values will be compared between the heliox and air-oxygen NIV. measured at baseline
Secondary heart rate after 15 minutes of heliox heart rate (HR, [bpm / beats per minute]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA), values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes of heliox ventilation
Secondary heart rate after 60 minutes of heliox heart rate (HR, [bpm / beats per minute]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA), values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes of heliox ventilation
Secondary heart rate after 180 minutes of heliox heart rate (HR, [bpm / beats per minute]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA), values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes of heliox ventilation
Secondary heart rate after 15 minutes of standard mixture heart rate (HR, [bpm / beats per minute]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA), values will be compared between the heliox and air-oxygen NIV. measured after 15 minutes since the return to standard mixture ventilation
Secondary heart rate after 60 minutes of standard mixture heart rate (HR, [bpm / beats per minute]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA), values will be compared between the heliox and air-oxygen NIV. measured after 60 minutes since the return to standard mixture ventilation
Secondary heart rate after 180 minutes of standard mixture heart rate (HR, [bpm / beats per minute]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA), values will be compared between the heliox and air-oxygen NIV. measured after 180 minutes since the return to standard mixture ventilation
Secondary baseline oxygen saturation SpO2 (peripheral capillary oxygen saturation, [%]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA) and the values will be compared between the heliox and air-oxygen NIV. measured at baseline
Secondary oxygen saturation after 15 minutes of heliox SpO2 (peripheral capillary oxygen saturation, [%]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA) and the values will be compared between the heliox and air-oxygen NIV. measured 15 minutes after heliox ventilation
Secondary oxygen saturation after 60 minutes of heliox SpO2 (peripheral capillary oxygen saturation, [%]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA) and the values will be compared between the heliox and air-oxygen NIV. measured 60 minutes after heliox ventilation
Secondary oxygen saturation after 180 minutes of heliox SpO2 (peripheral capillary oxygen saturation, [%]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA) and the values will be compared between the heliox and air-oxygen NIV. measured 180 minutes after heliox ventilation
Secondary oxygen saturation after 15 minutes of standard mixture SpO2 (peripheral capillary oxygen saturation, [%]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA) and the values will be compared between the heliox and air-oxygen NIV. measured 15 minutes since the return to standard mixture ventilation
Secondary oxygen saturation after 60 minutes of standard mixture SpO2 (peripheral capillary oxygen saturation, [%]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA) and the values will be compared between the heliox and air-oxygen NIV. measured 60 minutes since the return to standard mixture ventilation
Secondary oxygen saturation after 180 minutes of standard mixture SpO2 (peripheral capillary oxygen saturation, [%]) measured by NONIN Sen Smart Model X-100, Nonin Medical Inc., Plymouth, USA) and the values will be compared between the heliox and air-oxygen NIV. measured 180 minutes since the return to standard mixture ventilation
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06168149 - The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
Recruiting NCT03670732 - CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure N/A
Recruiting NCT02901652 - NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome N/A
Completed NCT02249143 - Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants N/A
Suspended NCT01852916 - NHFOV Versus NCPAP to Prevent Exubation Failure N/A
Completed NCT00208039 - Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates N/A
Recruiting NCT03510169 - Use of Gentle Synchronized Negative Pressure in Helping Babies Breathe N/A
Completed NCT00004494 - Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis Phase 1
Completed NCT00006058 - Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns N/A
Completed NCT00004805 - Study of the Effect of Four Methods of Cardiopulmonary Resuscitation Instruction on Psychosocial Response of Parents With Infants at Risk of Sudden Death N/A
Completed NCT03292562 - A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation N/A
Completed NCT05948332 - Definition and Management of Right Ventricular Injury in Adult Patients Receiving Extracorporeal Membrane Oxygenation
Completed NCT05038514 - The Effect of Music Therapy in COVID-19 Patients Given Prone Position N/A
Active, not recruiting NCT04079829 - Postoperative Respiratory Abnormalities
Completed NCT05462509 - Feasibility of Use of the PATH bCPAP and Oxygen Blenders Device With Neonates in Uganda N/A
Active, not recruiting NCT03808402 - The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
Completed NCT01812681 - Cord Blood 25(oh)-Vitamin D Level in Preterm Infants and Associated Morbidities N/A
Not yet recruiting NCT01440868 - Sustained Lung Inflation in the Delivery Room in Preterm Infants at High Risk of Respiratory Distress Syndrome N/A
Completed NCT01517958 - Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates N/A
Completed NCT01222247 - Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial Phase 3